ACTYM THERAPEUTICS, INC.

Profile

Company Names

ACTYM THERAPEUTICS, INC.

Addresses

626 BANCROFT WAY, SUITE A, BERKELEY, CA 94710

Phone Numbers

4156376691

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$25,344,381.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2023-06-28 
$11,238,333.00 
$27,539,376.00 
$16,301,043.00 
Equity 
1
2020-03-27 
$14,106,048.00 
$41,194,276.00 
$27,088,228.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BENJAMIN 
 
CHEN 
DIRECTOR
MOCHILA INC   |  ARKAMI, INC.   |  IMAGINAB, INC.   |  CARBITEX, INC.   |  ONCXERNA THERAPEUTICS, LTD.   |  HC BIOSCIENCE, INC.   |  ACTYM THERAPEUTICS, INC.
JULIE 
 
CHERRINGTON 
DIRECTOR
PATHWAY THERAPEUTICS, INC.   |  REVITOPE ONCOLOGY, INC.   |  ACTYM THERAPEUTICS, INC.
KANAD 
 
DAS 
DIRECTOR
ACTYM THERAPEUTICS, INC.
KANAD 
D 
DAS 
DIRECTOR
ACTYM THERAPEUTICS, INC.
JAMES 
D 
HUANG 
DIRECTOR
ACTYM THERAPEUTICS, INC.
AMIT 
D 
KUMAR 
DIRECTOR, PROMOTER
ACTYM THERAPEUTICS, INC.
RON 
 
MAZUMDER 
DIRECTOR
ACTYM THERAPEUTICS, INC.
CHRISTOPHER 
D 
THANOS 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
ACTYM THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-07-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-06-28 
2020-04-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-03-27 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#